| 标题 |
Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Kevin J. Harrington; Joshua Brody; M. Ingham; James Strauss; Sašo Čemerski; et al 出版日期:2018-10-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)